Assessment of Medical Expenditure for Patients With Breast Cancer in China: Evidence From Current Curative Expenditure by System of Health Accounts 2011-Reference-Cited by-同舟云学术

Assessment of Medical Expenditure for Patients With Breast Cancer in China: Evidence From Current Curative Expenditure by System of Health Accounts 2011

Published:2022-01 Issue:1 Volume:25 Page:77-83
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Zheng Ang,Zhu Yalan,Wang Yuhang,Liu Fang,Jin Feng,Zang Shuang,Wang Xin

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

3. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017;Curigliano;Ann Oncol,2017

4. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients;Zheng;BMC Cancer,2019

5. The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the Global Burden of Disease Study 2017;Ji;Front Oncol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of illness of breast cancer in low- and middle-income countries: a systematic review;Health Economics Review;2024-07-22

2. Financial toxicity and its risk factors among patients with cancer in China: A nationwide multisite study;Asia-Pacific Journal of Oncology Nursing;2024-05

3. Financial Toxicity Among Breast Cancer Patients;Cancer Nursing;2023-07-11

4. Application of a selective hospitalization model in the clinical practice of breast surgery;Medicine;2023-06-30